Condensed Consolidated Statement of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities
Net income	$ (28,344,000)	$ 13,900,000
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of debt issuance costs	1,187,000	42,000
Depreciation and amortization	21,197,000	4,859,000
Equity in undistributed earnings of associated companies, net of dividends	4,285,000	(186,000)
Indefinite-lived intangible asset impairment	38,000,000	0
Deferred compensation, deferred taxes and other, net	(22,988,000)	(6,842,000)
Share-based compensation	4,682,000	1,012,000
Gain on disposal of property, plant and equipment and other assets	(2,000)	(9,000)
Insurance settlement realized	(229,000)	(190,000)
Combination and other acquisition-related expenses, net of payments	(519,000)	(1,012,000)
Restructuring and related charges	1,716,000	0
Pension and other postretirement benefit expense	22,453,000	(1,346,000)
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:
Accounts receivable	2,322,000	(5,470,000)
Inventories	(10,162,000)	946,000
Prepaid expenses and other current assets	(3,263,000)	324,000
Restructuring liabilities	(4,841,000)	0
Accounts payable and accrued liabilities	(5,275,000)	(6,008,000)
Net cash provided by operating activities	20,219,000	20,000
Cash flows from investing activities
Investments in property, plant and equipment	(4,892,000)	(2,537,000)
Payments related to acquisitions, net of cash acquired	(3,160,000)	(500,000)
Proceeds from disposition of assets	0	8,000
Insurance settlement interest earned	31,000	65,000
Net cash used in investing activities	(8,021,000)	(2,964,000)
Cash flows from financing activities
Borrowings (repayments) on revolving credit facilities, net	205,500,000	(24,034,000)
Borrowings (repayments) on other long-term debt, net	(185,000)	86,000
Financing-related debt issuance costs	9,371,000,000	0
Repayment of long-term debt	(9,400,000)
Dividends paid	(6,828,000)	(4,935,000)
Stock options exercised, other	(696,000)	(1,489,000)
Acquisition of Noncontrolling Interest	(1,047,000)	0
Distributions to noncontrolling affiliate shareholders	(751,000)	0
Net cash provided by (used in) financing activities	186,622,000	(30,372,000)
Effect of foreign exchange rate changes on cash	(6,424,000)	1,004,000
Net increase in cash, cash equivalents and restricted cash	192,396,000	(32,312,000)
Cash, cash equivalents and restricted cash at the beginning of the period	143,555,000	124,425,000
Cash, cash equivalents and restricted cash at the end of the period	$ 335,951,000	$ 92,113,000